CASI PHARMACEUTICALS, INC. Equity Method Investment, Realized Gain (Loss) on Disposal
CASI PHARMACEUTICALS, INC. (CASIF) reported Equity Method Investment, Realized Gain (Loss) on Disposal of $5.33 million for the 12-month period ending 2022-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2025-03-31
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month |
|---|---|
| 2022-12-31 | $5.33M 20-F · filed 2025-03-31 |